Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Discussion of the entities and frameworks responsible for enforcing index rules and governance, including accountability and compliance checks.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Washington eyes a softer Basel III endgame, freeing up about $175B in excess bank capital. Crypto markets are watchin...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
Savers are rethinking cash holdings as rates rise. Here are three higher-yield alternatives traditional savings that ...
A stock can drop today for many reasons—some temporary, some signaling a bigger issue. This guide shows you how to ev...
A family of five confronts $85,000 in consumer debt and lays out a 3-to-4-year plan to regain financial footing, unde...
A 58-year-old accountant tests whether a portfolio built on JEPI and SPYI can replace a $90,000 salary. The plan hing...
SpaceX just won FAA clearance for a new re-entry capsule, a move that could redefine the economics of space data retu...
As markets wobble in 2026, investors are turning to a core portfolio cornerstone built on durable, recurring revenue....
Naples offers the quiet, gatehouse lifestyle many retirees crave, but the real cost retiring naples hinges on a steep...
A market strategist argues the AI urge to spend is cooling, transferring momentum from software giants to chipmakers ...